# clm_DC02ACC7A380

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 3,382,500,000 United States dollar  
valid_from: 2019-09-30  
valid_to: 2019-12-31  
published: 2019-10-25  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_FFAE8DCE11A7  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 3,382,500,000 United States dollar", as of 2019-09-30 (until 2019-12-31). Claim clm_DC02ACC7A380, https://asof.is/claim/clm_DC02ACC7A380, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947819000278/0000059478-19-000278-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-10-25  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947819000278/0000059478-19-000278-index.htm (primary, SEC EDGAR 10-Q Q3 FY2019, published 2019-10-25)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 2,780,500,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_DC02ACC7A380](/claim/clm_DC02ACC7A380.md) | [clm_E2C19C62764F](/claim/clm_E2C19C62764F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.